| 영문 | androgen | 한글 | 남성호르몬, 안드로겐 |
|---|---|---|---|
| 설명 | 남성의 이차 성징을 나타내게 하는 호르몬. 테스토스테론(testosterone), 안드로스테론(androsterone) 등이 있다. |
||
| PTCRA | percutaneous transluminal coronary rotational ablation |
|---|---|
| AIS | Androgen Insensitive Syndrome = Testicular Feminization Syndrome |
| AA | abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];... |
| AACSH | adrenal androgen corticotropic stimulating hormone |
| AASH | adrenal androgen stimulating hormone; American Association for the Study of Headache |
| CSAP | Cryosurgical ablation of the prostate |
|---|---|
| PTSMA | Percutaneous transluminal septal myocardial ablation |
| RFA | Radio-frequency ablation |
| RF-CA | Radiofrequency catheter ablation |
| TUNA | Transurethral needle ablation |
| ablation | 1. A carrying or taking away; removal. 2. <medicine> Extirpation. 3. <geology> Wearing away; superficial waste. See: tolerate. Origin: L. Ablatio, fr. Ablatus p. P. Of auferre to carry away; ab + latus, p. P. Of ferre carry: cf. F. Ablation. (11 Mar 1998) |
|---|---|
| catheter ablation | Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (dc-shock) or alternating current at radiofrequencies (usually 750 khz). The technique is used most often to ablate the av junction and/or accessory pathways in order to interrupt av conduction and produce av block in the treatment of various tachyarrhythmias. (12 Dec 1998) |
| electrode catheter ablation | A method of ablating the site of origin of arrhythmias whereby high energy electric shocks are delivered by intravascular catheters. (05 Mar 2000) |
| adrenal androgen | Any androgenic hormone of adrenocortical origin; e.g., dehydroepiandrosterone (and its sulfate), androstenedione, 11b-hydroxyandrostenedione. (05 Mar 2000) |
| adrenal androgen-stimulating hormone | A putative pituitary hormone that may be responsible for increased secretion of adrenal androgens at the time of puberty. (05 Mar 2000) |
| androgen | <endocrinology> General term for any male sex hormone in vertebrates. Androgens may be used in patients with breast cancer to treat recurrence of the disease. (14 May 1997) |
| androgen antagonists | Compounds which inhibit or antagonise the biosynthesis or actions of androgens. (12 Dec 1998) |
| androgen binding protein | A protein secreted by testicular Sertoli cells along with inhibin and mullerian inhibiting substance. Androgen binding protein probably maintains a high concentration of androgen in the seminiferous tubules. (05 Mar 2000) |
| androgen-binding proteins | Carrier proteins produced in the sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. Participate in the transport of androgens; include also synthetic androgens binding proteins. (12 Dec 1998) |
| androgen-dependent secretory protease | <enzyme> Glycoprotein from dog prostate; hydrolyzes arginine and lysine-containing amide and ester protease substrates Registry number: EC 3.4.99.- Synonym: ads-protease (26 Jun 1999) |
| androgen resistance syndromes | A class of disorders associated with 5a-steroid reductase deficiency, testicular feminization, and related disorders. Compare: steroid 5a-reductase, Reifenstein's syndrome, infertile male syndrome, testicular feminization syndrome. (05 Mar 2000) |
| androgen unit | The androgenic activity of 100 ug (0.1 mg) of crystalline androsterone as assayed by the comb growth response in capons. (05 Mar 2000) |
| receptors, androgen | Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|